AIM has 36-month beta value of -0.14. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AIM is 45.32M, and currently, short sellers hold a 1.09% ratio of that float. The average trading volume of AIM on April 23, 2024 was 232.12K shares.
AIM) stock’s latest price update
AIM ImmunoTech Inc (AMEX: AIM)’s stock price has decreased by -9.68 compared to its previous closing price of 0.47. However, the company has seen a -13.37% decrease in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-02 that AIM ImmunoTech Inc. (NYSE:AIM ) Q4 2023 Earnings Conference Call April 2, 2024 8:30 AM ET Company Participants Thomas Equels – Chief Executive Officer Dr. Christopher McAleer – Scientific Officer Conference Call Participants James Molloy – Alliance Global Partners Ed Woo – Ascendiant Capital Markets Operator Hello. And welcome to the AIM ImmunoTech Fiscal Year 2023 Update Conference Call and Webcast.
AIM’s Market Performance
AIM ImmunoTech Inc (AIM) has experienced a -13.37% fall in stock performance for the past week, with a 10.24% rise in the past month, and a 0.36% rise in the past quarter. The volatility ratio for the week is 13.40%, and the volatility levels for the past 30 days are at 12.30% for AIM. The simple moving average for the last 20 days is -14.19% for AIM stock, with a simple moving average of -15.83% for the last 200 days.
AIM Trading at -2.28% from the 50-Day Moving Average
After a stumble in the market that brought AIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.90% of loss for the given period.
Volatility was left at 12.30%, however, over the last 30 days, the volatility rate increased by 13.40%, as shares sank -5.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.53% upper at present.
During the last 5 trading sessions, AIM fell by -13.37%, which changed the moving average for the period of 200-days by -32.04% in comparison to the 20-day moving average, which settled at $0.4883. In addition, AIM ImmunoTech Inc saw -4.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AIM starting from BRYAN NANCY, who purchase 38,462 shares at the price of $0.39 back on Mar 21 ’24. After this action, BRYAN NANCY now owns 38,462 shares of AIM ImmunoTech Inc, valued at $15,000 using the latest closing price.
APPELROUTH STEWART, the Director of AIM ImmunoTech Inc, purchase 90,910 shares at $0.33 during a trade that took place back on Mar 15 ’24, which means that APPELROUTH STEWART is holding 239,765 shares at $30,000 based on the most recent closing price.
Stock Fundamentals for AIM
Current profitability levels for the company are sitting at:
- -156.25 for the present operating margin
- -0.36 for the gross margin
The net margin for AIM ImmunoTech Inc stands at -139.35. The total capital return value is set at -2.93. Equity return is now at value -118.94, with -64.84 for asset returns.
Based on AIM ImmunoTech Inc (AIM), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -95.37. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 49.78.
Currently, EBITDA for the company is -31.66 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 80.38. The receivables turnover for the company is 0.17for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.68.
Conclusion
To put it simply, AIM ImmunoTech Inc (AIM) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
